Can a simple finger test predict blood vessel problems after transplant?
NCT ID NCT05029752
First seen Jun 25, 2026 · Last updated Jul 16, 2026 · Updated 3 times
Summary
This study looked at whether a device called Vendys II, which measures blood vessel function by tracking finger temperature after a brief blood flow restriction, could be used in children and young adults (ages 6-26) undergoing stem cell transplants. The goal was to see if it was feasible to measure vascular health in this group. The study was terminated early and enrolled only 27 participants.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could provide a simple, non-invasive way to monitor blood vessel health in young transplant patients.
- What could go wrong
- The study was terminated early with only 27 participants, so results are limited. It only tested feasibility, not whether the device improves outcomes.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ENDOTHELIAL are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
M D Anderson Cancer Center
Houston, Texas, 77030, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a stent heal leg ulcers that Won't close?
- Could a pill shield the brain and kidneys during heart surgery?
- Tiny particles in blood may signal hidden heart risk in hypertensive children
- AI could slash MRI scan times without sacrificing quality
- Ancient herb gotu kola put to the test for healthier arteries in aging
- Could cocoa and veggies protect against pregnancy complications?